NR1D1 and Duchenne muscular dystrophy: We also report that NR1D1 pharmacological activation by synthetic ligands may reveal therapeutic interests, because it improved calcium homeostasis in cells from patients with DMD and alleviated the myopathy phenotype in mdx/Utr+/– mice.